StockTipsArenaBeta

SELL Ajanta Pharma Limited — BOB Capital Markets

SELLAjanta Pharma Limited
Ajanta Pharma share price target & all analyst calls

byBOB Capital MarketsHorizon: NA (inferred 1 year)31 Jan 2025via Institutional / Brokerage Research

Entry₹2,694.45Inferred
Target₹2,288
Total upside +15.08% (call closed)
Stop lossNot given
At expiry₹2,781.930 Jan 2026, 3:30 pm
Expired-3.25%
Follow BOB Capital Markets for new calls(63% target hit, 358 closed calls)Get alertsWatch AJANTPHARM for new buy/sell callsGet alertsSee 3 active Long-term calls on AJANTPHARMSee 274 active Long-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this SELL call — facts from public sources, machine-classified. Not investment advice.

As of 25 Oct, 10:51 pm IST
0 supporting1 opposing
Supports the SELL call (0)

Nothing found in this tip’s window yet.

Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the SELL call (1)

1 other SEBI-registered advisor has an active long-term BUY call on this stock, issued in the last 14 days

Advisor consensus · same horizon·30 Jan · today

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Ajanta Pharma

All analyst calls on Ajanta Pharma

More from BOB Capital Markets

Every call and its outcome